Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2020-12-09 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
安信证券股份有限公司关于公司变更部分募集资金投资项目实施地点的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from a sponsoring securities firm (安信证券股份有限公司) regarding a change in the implementation location of certain investment projects funded by proceeds from a non-public stock issuance by 盈康生命科技股份有限公司. It references regulatory approvals, the amount and use of raised funds, and confirms compliance with relevant laws and internal procedures. The document does not contain financial statements or detailed financial results but is a verification and opinion on a specific change related to the use of raised capital. It is not an annual or interim report, earnings release, or management discussion. It is also not a proxy, voting result, or director dealing report. The document is a regulatory compliance and verification filing related to capital use changes, but it is not announcing a new financing or capital structure change itself. Given the nature of the document as a formal verification opinion on a change in the use of raised funds, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories. The document length is short (2293 characters), and it is not an announcement of a report publication but a substantive regulatory opinion document. Therefore, the classification is RNS with high confidence.
2020-12-09 Chinese
关于召开2020年第四次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice for convening the 2020 fourth extraordinary general meeting of shareholders of 盈康生命科技股份有限公司. It includes details about the meeting date, time, location, agenda items to be voted on, voting procedures including online voting, and proxy authorization forms. There are no financial statements or detailed financial analysis present. The document is primarily an announcement informing shareholders about the meeting and how to participate and vote on proposals. It does not contain the results of the vote or the meeting minutes. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-12-09 Chinese
关于子公司与海尔金融保理（重庆）有限公司签署保理业务《意向合作协议》暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a related-party transaction between the company's subsidiary and a financial entity controlled by the company's actual controller. It includes descriptions of the transaction, approvals by the board and supervisory committee, independent directors' opinions, and compliance with regulatory requirements. The document is an announcement of a specific transaction (related-party transaction) and not a financial report, earnings release, or management discussion. It does not contain financial statements or quarterly/yearly results but focuses on the disclosure of a capital/financing update related to factoring business cooperation and financing arrangements. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2020-12-09 Chinese
第五届监事会第三次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the third (extraordinary) meeting of the fifth Supervisory Board of Yingkang Life Technology Co., Ltd. It details the meeting's convening, attendance, and voting results on various company matters such as related-party transactions, changes in investment project locations, and cash management adjustments. The document is an official disclosure of board-level decisions and meeting outcomes, not a full report or financial statement. It does not contain financial data or detailed management analysis but rather the results of supervisory board deliberations and approvals. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management bodies. The document length is 2445 characters, relatively short and focused on meeting resolutions, supporting this classification. Therefore, the filing type code is MANG with high confidence.
2020-12-09 Chinese
关于公司完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 盈康生命科技股份有限公司 regarding completion of changes in business registration details including registered address, registered capital, and business scope. It references approvals from regulatory bodies and shareholder meetings but does not contain financial statements or detailed financial data. The document length is short (1882 characters) and it primarily informs about corporate registration changes and approvals. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate changes and does not qualify as a full financial report or other specific filing type.
2020-11-06 Chinese
关于公司注册地址、办公地址及联系方式变更的公告
Regulatory Filings Classification · 100% confidence The document is a short announcement (823 characters) about the change of the company's registered address, office address, and contact information. It does not contain any financial data, management discussion, voting results, or regulatory certifications. It is not a report or detailed filing but a notification of administrative changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2020-11-06 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.